Use of Disposable Stethoscope Covers for Reduction of Stethoscope MRSA Contamination
1 other identifier
interventional
1
1 country
1
Brief Summary
This is a prospective pilot study using a randomized, controlled, single blinded, crossover trial design, evaluating the effect of daily antimicrobial stethoscope diaphragm covers versus uncovered stethoscope. Stethoscopes will be cleaned Sani-cloth germicidal disposable wipes which are effective against MRSA. Each participant will then be randomly assigned to 7 days in either the intervention or the control arm. At the end of the 7 days participants stethoscopes will be cleaned again. This will be followed by another 7 days in the arm that they are not in during the first 7 days. The primary endpoint is MRSA colony count from stethoscope diaphragms cultures at 7 days, focusing on the difference between the intervention and the control periods. The secondary endpoint is the rate of hospital acquired MRSA infection in patients treated by residents during each period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 2, 2018
CompletedStudy Start
First participant enrolled
June 8, 2018
CompletedFirst Posted
Study publicly available on registry
July 26, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 5, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
April 5, 2019
CompletedSeptember 13, 2019
September 1, 2019
10 months
May 2, 2018
September 12, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
MRSA colony count cultured from stethoscope diaphragms
Total CFU of each selected pathogen at 7 days compared by paired Mann-Whitney U tests, with each patient serving as their own control
7 Days
Secondary Outcomes (1)
Rate of hospital acquired MRSA infection in patients treated by participating residents
14 Days
Study Arms (2)
Antimicrobial Stethoscope Diaphragm Covers
ACTIVE COMPARATORUncovered Stethoscopes
ACTIVE COMPARATORInterventions
Patients will receive package with instructions to use stethoscope cover, and are then instructed to switch in 7 days
Patients receive instruction to begin with no covers, and are then instructed to switch in 7 days
Eligibility Criteria
You may qualify if:
- Internal Medicine Residents
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
New York University School of Medicine
New York, New York, 10016, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Marwa Moussa, MD
NYU Langone Health
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 2, 2018
First Posted
July 26, 2018
Study Start
June 8, 2018
Primary Completion
April 5, 2019
Study Completion
April 5, 2019
Last Updated
September 13, 2019
Record last verified: 2019-09